No Data
No Data
Merrimack Pharmaceuticals | 10-Q: Quarterly report
Vicore Expands and Strengthens Its Board of Directors
STOCKHOLM, SWEDEN / ACCESSWIRE / May 14, 2024 / Vicore Pharma Holding Stockholm, May 14, 2024 - Vicore Pharma Holding AB, a clinical-stage biopharmaceutical company unlocking the potential of a new class of
Merrimack Pharmaceuticals Shareholders OK Dissolution Plan
By Ben Glickman Merrimack Pharmaceuticals said Friday that its shareholders had approved its plan of dissolution and an accompanying liquidating cash dividend. The dividend will be $15.10 a share, e
Express News | Merrimack Pharmaceuticals Inc: Merrimack's Common Stock Will Trade on Nasdaq Through May 17, 2024 and Will Delist From Nasdaq on May 20, 2024
Express News | Merrimack Pharmaceuticals, Inc. Announces Stockholder Approval of Plan of Dissolution and Cash Liquidating Dividend Amount of $15.10 per Share of Common Stock
Express News | Merrimack Set for $15.10 per Share Liquidating Dividend
Jaguar8 : I love the milestone payment but dissolution weighed it down
TrytosaveabitOP Jaguar8: Yup! I believe you’re correct